Boston Scientific

YTD

ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.

CEO

Michael F. Mahoney

CEOMichael F. Mahoney

Employees

53,000

Employees53,000

Headquarters

Marlborough, Massachusetts

HeadquartersMarlborough, Massachusetts

Founded

1979

Founded1979

Employees

53,000

Employees53,000

BSX Key Statistics

Market cap

111.79B

Market cap111.79B

Price-Earnings ratio

38.21

Price-Earnings ratio38.21

Dividend yield

—

Dividend yield—

Average volume

27.99M

Average volume27.99M

High today

$76.37

High today$76.37

Low today

$74.20

Low today$74.20

Open price

$74.54

Open price$74.54

Volume

13.45M

Volume13.45M

52 Week high

$109.50

52 Week high$109.50

52 Week low

$72.69

52 Week low$72.69

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $74.72. The company's market cap stands at 111.79B, with a P/E ratio of 38.21.

On 2026-02-13, Boston Scientific(BSX) stock moved within a range of $74.20 to $76.37. With shares now at $74.72, the stock is trading +0.7% above its intraday low and -2.2% below the session's peak.

Trading activity shows a volume of 13.45M, compared to an average daily volume of 27.99M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $72.69.

BSX News

Simply Wall St 10h

Does Boston Scientific’s 2026 Double-Digit Sales Outlook and Leadership Shift Change The Bull Case For BSX?

Boston Scientific’s fourth-quarter 2025 results, reported on February 4, 2026, showed sales rising to US$5,286 million and net income to US$672 million, alongsi...

Simply Wall St 5d

Boston Scientific Valuation Check After Earnings Strength And Softer Electrophysiology And Watchman Trends

Advertisement Earnings catalyst and shifting sentiment Boston Scientific (BSX) is back in focus after its latest earnings report, where solid year over year g...

TipRanks 5d

Boston Scientific: Multi-Year Double-Digit Growth Outlook Makes Share Pullback a Buy Opportunity

Citi analyst Joanne Wuensch reiterated a Buy rating on Boston Scientific yesterday and set a price target of $102.00. Joanne Wuensch has given his Buy rating d...

Analyst ratings

97%

of 34 ratings

Buy

97.1%

Hold

2.9%

Sell

More BSX News

TipRanks 5d

Boston Scientific: Durable Growth, Expanding EP Opportunity, and Upside-Skewed Valuation Justify Buy Rating

J.P. Morgan analyst Robbie Marcus maintained a Buy rating on Boston Scientific today and set a price target of $100.00. Robbie Marcus has given his Buy rating...

Simply Wall St 6d

Penumbra Sale To Boston Scientific Recasts Growth Story For Investors

Penumbra (NYSE:PEN) is set to be acquired by Boston Scientific in a US$14.5b deal, following the release of strong quarterly results. The transaction, announce...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.